TABLE 3.
Procedural and postprocedural characteristics.
| Patients | Approach | TAVR devices used | Procedural duration (min) | Fluoroscopic duration (min) | Predila -tation |
Postdila -tation |
Procedural success | Postprocedural aortic status | Procedural complications | Length of hospital stay (days) | In-hospital and 30-day complications | 1-year LVEF | 1-year NYHA FC class |
| Patient 1 | Transapical | J-Valve 27 mm | 130 | 15 | No | No | Yes | Normal | No | 9 | No | 51% | III |
| Patient 2 | Transapical | J-Valve 29 mm | 110 | 17 | No | No | Yes | Normal | Hemorrhage, needed blood transfusion | 5 | No | 48% | II |
| Patient 3 | Transapical | J-Valve 27 mm | 110 | 13 | No | No | Yes | Normal | No | 5 | No | 51% | I |
| Patient 4 | Transapical | J-Valve 29 mm | 100 | 15 | No | No | Yes | Normal | No | 4 | No | 54% | I |
| Patient 5 | Transfemoral | Venus-A 32 mm | 60 | 22 | Yes | No | Yes | Normal | Trivial PVL | 7 | A-V block | 45% | II |
LVEF, left ventricular ejection fraction; NYHA FC, New York Heart Association functional class; PVL, paravalvular leak; TAVR, transcatheter aortic valve replacement.